Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | APPL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | LRRC37A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | HOXD11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CLECL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | BTD | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | CCDC28A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | BRSK2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | N4BP2L1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | SORD | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | RGMB | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |